Local Coverage Determination (LCD)

Non-Invasive Peripheral Arterial Vascular Studies

L35761

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L35761
Original ICD-9 LCD ID
Not Applicable
LCD Title
Non-Invasive Peripheral Arterial Vascular Studies
Proposed LCD in Comment Period
N/A
Source Proposed LCD
DL35761
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 10/26/2023
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
07/01/2015
Notice Period End Date
08/15/2015
AMA CPT / ADA CDT / AHA NUBC Copyright Statement

CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2023, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description

Review completed with no change in coverage. 

Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

Italicized font represents CMS national language/wording copied directly from CMS Manuals or CMS transmittals. Contractors are prohibited from changing national NCD language/wording.

Title XVIII of the Social Security Act section 1833 (e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.

Title XVIII of the Social Security Act section 1862 (a) (1) (A) allows coverage and payment of those items or services that are considered to be medically reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Title XVIII of the Social Security Act section 1862 (a) (1) (D) excludes Medicare payment for any expenses incurred for items or services that are investigational or experimental.

Title XVIII of the Social Security Act section 1862 (a) (7) excludes routine physical examinations and services from Medicare coverage.

42 CFR, Section 410.32 Diagnosis x-ray tests, diagnostic laboratory tests, and other diagnostic indicates that diagnostic tests may only be ordered by the treating physician (or other treating practitioner acting within the scope of his or her license and Medicare requirements) who furnishes a consultation or treats a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary’s specific medical problem. Tests not ordered by the physician or other qualified non-physician provider who is treating the patient are not reasonable and necessary (42 CFR 411.15(k) (1).

42 CFR, Section 410.32 (b) Diagnostic x-ray and other diagnostic tests. (1) Basic rule … all diagnostic x-ray and other diagnostic tests covered under section 1861(s)(3) of the Act and payable under the physician fee schedule must be furnished under the appropriate level of supervision by a physician as defined in section 1861® of the Act. Services furnished without the required level of supervision are not reasonable and necessary. (42 CFR 411.15(k)(1)).

CMS Pub 100-02 Medicare Benefit Policy Manual, Chapter 15 – Covered Medical and Other Health Services, Section 80 – Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests.

CMS Pub 100-03 Medicare National Coverage Determinations (NCD) Manual, - Chapter 1 – Coverage Determinations Part 1, Section 20.14 – Plethysmography; and
Part 4 Sections
220.5 - Ultrasound Diagnostic Procedures,
220.11 – Thermography, and
300.1 - Obsolete or Unreliable Diagnostic Tests.

CMS Pub 100-04 Medicare Claims Processing Manual, Chapter 7 – SNF Part B Billing (Including Inpatient Part B and Outpatient Fee Schedule), Section 50 – Billing Part B Radiology Services and Other Diagnostic Procedures; and
Chapter 13 – Radiology Services and Other Diagnostic Procedures, Sections –
10.1 - Billing Part B Radiology Services and Other Diagnostic Procedures and
20 – Payment Conditions for Radiology Services.

CMS Pub 100-08, Medicare Program Integrity Manual, Chapter 13 – Local Coverage Determinations, Section 13.5.1 – Reasonable and Necessary Provisions in LCDs.

CMS Publication 100-09, Medicare Contractor Beneficiary and Provider Communications Manual, Chapter 5 - Correct Coding Initiative.

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

Overview
Non-invasive peripheral arterial vascular studies utilize ultrasonic Doppler and physiologic studies to assess the irregularities in blood flow in arterial systems. These noninvasive peripheral arterial vascular studies include the patient care required to perform the studies, supervision of the studies, and interpretation of study results, with copies for patient records of test results and analysis of all data, including bi-directional vascular flow or imaging when provided.

Diagnostic tests must be ordered by the physician who is treating the beneficiary and the results used in the management of the beneficiary’s specific medical problem. Services are deemed medically necessary when all of the following conditions are met:

  1. Signs/symptoms of ischemia or altered blood flow are present;
  2. The information is necessary for appropriate medical and/or surgical management;
  3. The test is not redundant of other diagnostic procedures that must be performed. Although, in some circumstances, non-invasive vascular tests are complimentary, such as MRA and duplex, where the latter may confirm an indeterminate finding or demonstrate the physiologic significance of an anatomic stenosis (especially in the lower extremity arterial system).

Definitions:

Duplex Scans: Duplex combines Doppler and conventional ultrasound, allowing the structure of blood vessels, how the blood is flowing through the vessels, and whether there is any obstruction in the vessels to be seen. Color Doppler produces a picture of the blood vessel, and a computer converts the Doppler sounds into colors overlaid on the image, representing information about the speed and direction of blood flow. Using spectral Doppler analysis, the duplex scan images provide anatomic and hemodynamic information, identifying the presence of any stenosis or plaque in the arteries. Duplex scans are in real-time.

Physiologic Studies: Functional measurement procedures including ankle/brachial index measurement (ABI), blood pressure and physiologic waveforms, Doppler ultrasound, segmental pressure measurements, blood pressure measurements, transcutaneous oxygen tension measurements, exercise testing, and/or plethysmography. These studies do not involve imaging.

The most common is the ABI test, which compares the blood pressure measured at the ankle with the blood pressure measured at the arm (brachial) using a Doppler stethoscope and blood pressure cuff.

Doppler Ultrasound uses reflected sound waves called physiologic waveforms to evaluate the blood as it flows through an artery. The waveforms bounce off blood cells in a motion that causes a change in the pitch of the sound, called the Doppler effect. These can be measured at a single level, or at segmental (various) limb levels. If there is no blood flow, the pitch does not change.

Exercise testing can be used to analyze the functional significance of vascular disease by reassessing the blood pressure with the Doppler stethoscope after completion of an appropriate amount of stress testing.

Plethysmography is a measurement of the volume of an organ or limb section, or flow rate, in response to the inflation and deflation of a BP cuff.

Transcutaneous oxygen tension measurement may be done in any area of interest, usually the foot or calf. It measures the influx of blood that provides oxygen for diffusion to the skin.

Peripheral Arterial Examinations
In general, noninvasive studies of the arterial system are to be utilized when invasive correction is contemplated, or severity of findings dictates noninvasive study follow up. The latter may also be followed with physical findings and/or progression or relief of signs and/or symptoms. It can be useful in pre-operative evaluation of patients with known arteriosclerotic diseases who will be undergoing surgeries which put them at high risk for vascular complications (i.e. CABG, cranial surgeries etc.). It can be used for surveillance to ensure graft patency post-operatively.

Non-invasive peripheral arterial studies performed to establish the level and/or degree of arterial occlusive disease are considered medically necessary if:

  1. Signs and/or symptoms of possible limb ischemia are present; and
  2. The patient can be medically managed or is a candidate for percutaneous, surgical, diagnostic, or therapeutic procedures.

Acute ischemia is characterized by the sudden onset of severe pain, coldness, numbness, and pallor of the extremity. Chronic ischemia or critical limb ischemia can have intermittent claudication, pain at rest, diminished pulse, ulceration, and gangrene.

Indications:

  1. Signs and symptoms of reduced peripheral blood flow that result in tissue loss, gangrene, or pre-gangrenous changes. Duplex scans are not always needed but may be helpful in defining the regions for arteriography (angiograms), thus limiting the contrast load to the patient.
  2. Suspected arterial occlusive disease with symptoms including claudication, rest pain, ischemic tissue loss, aneurysm, and/or arterial embolization. Claudication is defined as pain occurring within 1 block or less of walking and/or of such severity that it interferes significantly with the patient's occupation or lifestyle. Rest pain of vascular disease (typically including the forefoot), is usually associated with absent pulses, which becomes increasingly severe with elevation and diminishes with placement of the leg in a dependent position.
  3. Evaluation of grafts or other vascular intervention when signs and symptoms of ischemia, rejection, and/or vascular disease are present.
  4. The monitoring of sites of previous surgical interventions, including sites of previous bypass surgery with either synthetic or autologous vein grafts.
  5. The monitoring of sites of various percutaneous interventions, including angioplasty,
    thrombolysis/thrombectomy, atherectomy, or stent placement.
  6. Follow-up for progression of previously identified disease, such as documented stenosis in an artery that has not undergone intervention, aneurysms, atherosclerosis, or other occlusive diseases.
  7. The evaluation of suspected vascular and perivascular abnormalities, including masses, aneurysms, pseudoaneurysms, arterial dissections, vascular injuries, arteriovenous fistulae, thromboses, emboli, various communications between arteries and veins, or vascular malformations.
  8. Mapping of arteries prior to surgical interventions.
  9. Clarifying or confirming the presence of significant arterial abnormalities identified by other imaging modalities.
  10. Evaluation of arterial integrity in the setting of blunt or penetrating trauma with suspicion of vascular injury (including complications of diagnostic and/or therapeutic procedures).
  11. Evaluation of patients suspected of thoracic outlet syndrome, with symptoms of positional numbness, pain, tingling, or a cold hand.
  12. Allen’s test to establish patency of palmar arch.

Limitations:
Peripheral artery studies may not be considered medically necessary if only the following signs and symptoms are present:

  1. Continuous burning of the feet as it is considered to be a neurologic symptom.
  2. Nonspecific leg pain and pain in a limb as a single diagnosis is too general to warrant further investigation, unless they are related to other signs and symptoms.
  3. Peripheral edema will only be covered with arterial occlusive disease in the immediate postoperative period, in association with another inflammatory process, or in association with rest pain.
  4. Absence of peripheral pulses, e.g., dorsalis pedis or posterior tibial, is not an indication to proceed beyond the physical examination unless the absent pulses can be related to other signs and/or symptoms.
  5. Screening of the asymptomatic patient is not covered.
  6. Ankle-brachial index alone or when part of the physical examination, and not as part of the limited or complete bilateral physiologic studies, is not separately covered.
  7. The use of a simple hand-held Doppler device that does not produce hard copy or that produces a record that does not permit analysis of bidirectional vascular flow, is considered to be part of the physical examination of the vascular system and is not separately reimbursable.

Non-covered peripheral arterial study testing methods include thermography, mechanical oscillometry, inductance or capacitance plethysmography, photoelectric plethysmography, differential plethysmography, and light reflective rheography.

Credentialing and Accreditation Standards
The accuracy of non-invasive vascular diagnostic studies depends on the knowledge, skill, and experience of the technologist and interpreter. Consequently, the physician performing and/or interpreting the study must be capable of demonstrating documented training and experience. A vascular diagnostic study may be personally performed by a physician, a certified technologist, or in a certified vascular testing lab.

Services will be considered medically reasonable and necessary only if performed by appropriately trained providers.

  1. All non-invasive vascular diagnostic studies must be performed meeting at least one of the following:
    1. performed by a licensed qualified physician, or
    2. performed by a technician who is certified in vascular technology, or
    3. performed in facilities with laboratories accredited in vascular technology
  2. A licensed qualified physician for these services is defined as:
    1. Having trained and acquired expertise within the framework of an accredited residency or fellowship program in the applicable specialty/subspecialty in ultrasound (US) or must reflect equivalent education, training, and expertise endorsed by an academic institution in ultrasound or by applicable specialty/subspecialty society in ultrasound, or
    2. Has the Registered Vascular Technologist (RVT), Registered Physician Vascular Interpretation (RPVI), or American Society of Neuroimaging (ASN): Neuroimaging Subspecialty Certification; and
    3. Is able to provide evidence of proficiency in the performance and interpretation of each type of diagnostic procedure performed.
  3. Nonphysician personnel performing tests must demonstrate basic qualifications to perform tests and have training and proficiency as evidenced by licensure or certification by an appropriate State health or education department. In the absence of a State licensing board, non-physician personnel must be certified by an appropriate national credentialing body.  Appropriate personnel certification includes the American Registry of Diagnostic Medical Sonographers (ARDMS) or Registered Vascular Technologist (RVT) credential; or Cardiovascular Credentialing International’s Registered Vascular Specialist (RVS).
  4. Laboratories must be certified by one of the following:
    • Intersocietal Accreditation Commission (IAC),
    • American College of Radiology (ACR),
    • Joint Commission (Vascular lab certification would need to be noted under the main certification either under inpatient or ambulatory care depending on where the test is being performed), or
    • DNV-GL (specific for hospitals only)
    According to which certifying body listed above is selected, that accrediting body’s standards must be followed.
  5. Transcutaneous oxygen tension measurement should be performed by personnel possessing the following credentials obtained from the National Board of Diving and Hyperbaric Medicine Technology (NBDHMT): Certified Hyperbaric Technologist (CHT), or Certified Hyperbaric Registered Nurse (CHRN).
Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description
N/A

Revenue Codes

Code Description
N/A

CPT/HCPCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information

Documentation
Adequate documentation is essential for high-quality patient care and to demonstrate the reasonableness and medical necessity of the study(ies). Documentation must support the criteria as described in the Coverage Indications, Limitations, and/or Medical Necessity section of this LCD. There should be a permanent record of the studies performed and the interpretation. The documentation should include a description of the studies performed and any contrast media and/or radiopharmaceuticals used. Any known significant patient reaction or complications should be recorded. Comparison with prior relevant studies needs to be addressed in the documentation along with both normal and abnormal findings. Variations from normal should be documented along with measurements. The report should address or answer any specific clinical questions. If there are factors that prevent answering the clinical questions, this should be explained in the documentation. Retention of the ultrasound examination images and final interpretation should be consistent both with clinical need and with relevant legal and local health care facility requirements.

If the provider of the study is other than the ordering/referring physician/nonphysician practitioner, that provider must maintain a copy of the test results and interpretation, along with copies of the ordering/referring physician/nonphysician practitioner’s order for the studies. This order is required to provide adequate diagnostic information to the performing provider. The physician/nonphysician practitioner must state the clinical indication/medical necessity for the study in his/her order for the test. The provider is responsible for ensuring the medical necessity of procedures and maintaining the medical record, which must be available to Medicare upon request. Results of all testing must be shared with the referring physician. Non-invasive vascular studies are medically reasonable and medically necessary only if the outcomes will be utilized in the clinical management of the patient.

Utilization Guidelines
Each patient’s condition and response to treatment must medically warrant the number of services reported for payment. Medicare requires the medical necessity for each study reported to be clearly documented in the patient’s medical record.

Frequency of follow-up studies will be carefully monitored for medical necessity and it is the responsibility of the physician/provider to maintain documentation of medical necessity in the patient’s medical record.

Generally, it is expected that noninvasive vascular studies would not be performed more than once in a year, excluding inpatient hospital (21) and emergency room (23) places of services.

Only one preoperative scan is considered reasonable and necessary for bypass surgery. If a more current preoperative scan is indicated for a patient with multiple comorbidities having difficulty being stabilized for surgery or a change in condition, the medical record would need to support the medical necessity of the second scan.

In the immediate post-operative period, patients may be studied if re-established pulses are lost, become equivocal, or if the patient develops related signs and/or symptoms of ischemia with impending repeat intervention.

The frequency of medically necessary follow-up noninvasive vascular studies post-angioplasty is dictated by the vascular distribution treated.

Pre-surgical conduit mapping of the radial artery(ies) should only be accompanied by vein-mapping studies when the arterial studies demonstrate a non-acceptable conduit, or an insufficient conduit is available for multiple bypass procedures.

Duplex scanning and physiologic studies may be reimbursed during the same encounter if the physiologic studies are abnormal and/or to evaluate vascular trauma, thromboembolic events or aneurysmal disease. The documentation must support the medical necessity.

Assessment of the Ankle brachial indices (ABI) only is considered part of the physical examination and is not covered according to Title XVIII of the Social Security Act section 1862 (a) (7) which excludes routine physical examinations and services from Medicare coverage.

Preventive and/or screening services unless covered in Statute are not covered by Medicare.

Sources of Information

ACR. (2012, Amended 2014). ACR-AIUM-SIR-SRU Practice parameter for the performance of physiologic evaluation of extremity arteries. American College of Radiology Practice Parameter. Resolution 39. pp. 1-7.

ACR. (Revised 2014). ACR-AIUM-SRU Practice parameter for the performance of peripheral arterial ultrasound using color and spectral Doppler. American College of Radiology Practice Parameter. Resolution 26. pp.1-11.

ACR. (Revised 2014). ACR Practice parameter for communication of diagnostic imaging findings. American College of Radiology Practice Parameter. Resolution 11. pp. 1-9.

ACR. (2011, Amended 2014). ACR-SPR-SRU Practice parameter for performing and interpreting diagnostic ultrasound examinations. American College of Radiology. Resolution 39. pp. 1-6.

ACR. (Revised 2011). ACR Technical standard for diagnostic medical physics performance monitoring of real time ultrasound equipment. American College of Radiology Practice Parameter. Resolution 3. pp.1-7.

ACR. (2010, Sep 9). Ultrasound accreditation program requirements. American College of Radiology. pp.1-10.

Intersocietal Accreditation Commission. (2013, Jun 15). IAC Standards and Guidelines for Vascular Testing Accreditation. Pages 1-67.

Intersocietal Accreditation Commission. (2010, Apr). ICAVL Standards for accreditation in noninvasive vascular testing. Parts I through VII. Pages 1-73.

Bibliography
  1. Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index. Circulation. 2012;126(24):2890-2909. doi:10.1161/cir.0b013e318276fbcb
  2. Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ. Guidelines for noninvasive Vascular LABORATORY Testing: A report from the American Society of echocardiography and the Society of Vascular medicine and biology. Journal of the American Society of Echocardiography. 2006;19(8):955-972.
    doi:10.1016/j.echo.2006.04.019
  3. Mohler ER, Gornik HL, Gerhard-Herman M, Misra S, Olin JW, Zierler RE. ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral Vascular ultrasound and Physiological testing Part I: Arterial ultrasound and Physiological testing. Journal of the American College of Cardiology. 2012;60(3):242-276. doi:10.1016/j.jacc.2012.02.009

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
10/26/2023 R17

Posted 10/26/2023 Review completed 10/03/2023 with no change in coverage.

  • Other (Review completed)
10/01/2021 R16

10/01/2021 Clarified information under Credentialing and Accreditation Standards regarding certification as a certified vascular testing lab. Sources of Information and Bibliography updated to correct format. Review completed 08/13/2021.

  • Other (Review completed)
11/01/2019 R15

Change Request 10901 Local Coverage Determinations (LCDs): it will no longer be appropriate to include Current Procedure Terminology (CPT)/Health Care Procedure Coding System (HCPCS) codes or International Classification of Diseases Tenth Revision-Clinical Modification (ICD-10-CM) codes in the LCDs. All CPT/HCPCS, ICD-10 codes, and Billing and Coding Guidelines have been removed from this LCD and placed in the Billing and Coding Article related to this LCD. Consistent with Change Request 10901, if any language from IOMs and/or regulations was present in the LCD, it has been removed and the applicable manual/regulation has been referenced.

  • Revisions Due To Code Removal
10/01/2019 R14

09/26/2019 ICD-10 code update: description change Group 1 for I70.238 and I70.248. Review done 08/13/2019.

  • Revisions Due To ICD-10-CM Code Changes
06/01/2018 R13

06/01/2018 Annual review done 05/02/2018. Typographical errors corrected. No change in coverage.

  • Other (Annual Review)
11/01/2017 R12

11/01/2017 Added G45.8 to Group 1 codes.

  • Revisions Due To ICD-10-CM Code Changes
10/01/2017 R11

10/01/2017 ICD-10 code updates: Added the following codes to Group 1: L97.115, L97.116, L97.118, L97.125, L97.126, L97.128, L97.215, L97.216, L97.218, L97.225, L97.226, L97.228, L97.315, L97.316, L97.318, L97.325, L97.326, L97.328, L97.415, L97.416, L97.418, L97.425, L97.426, L97.428, L97.515, L97.516, L97.518, L97.525, L97.526, L97.528, L97.815, L97.816, L97.818, L97.825, L97.826, L97.828, L97.915, L97.916, L97.918, L97.925, L97.926, and L97.928. Added the phrase “claudication and” to the asterisk explanation phrase for “use for claudication and intermittent claudication” at the end of Group 1 for code I73.9. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

 

  • Revisions Due To ICD-10-CM Code Changes
  • Other
06/01/2017 R10 06/01/2017 Annual review done 05/03/2017. Corrected typographical errors. No change in coverage.
  • Other ((Annual Review))
10/01/2016 R9 10/01/2016 ICD-10 code updates added codes: I77.76, I77.77, I97.620, I97.621, I97.622, I97.630, I97.631, and I97.638 I97.640, I97.641, I97.648. Deleted code I97.62. Code description changed codes: I77.79, I97.610, I97.618, T82.818A, T82.828A, T82.838A, T82.848A, T82.858A, and T82.868A. Added DNV-GL to the list of accrediting bodies.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R8 06/01/2016 Annual review completed 05/06/2016. Corrected typos. Billing and Coding guideline removed.
  • Other (annual review)
10/01/2015 R7 04/01/2016 Added R09.89 to Group 1 Codes effective 10/01/2015.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R6 03/01/2016 Added I71.3, I71.4, and I72.3 to Group 1 Codes effective 10/01/2015.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R5 01/01/2016 Added the following codes to Group 1 Codes effective 10/01/2015: I70.201, I70.202, I70.203, I70.208 I70.218, I70.228, I70.235, I70.238, I70.245, I70.248, I70.268, I70.291, I70.292, I70.293, I70.298, I70.301, I70.302, I70.303, I70.308, I70.401, I70.402, I70.403, I70.408, I70.418, I70.428, I70.435, I70.438, I70.445, I70.448, I70.468, I70.498, I70.501, I70.502, I70.503, I70.508, I70.518, I70.528, I70.535, I70.538, I70.545, I70.548, I70.568, I70.598, I70.601, I70.602, I70.603, I70.608, I70.618, I70.628, I70.635, I70.638, I70.645, I70.648, I70.65, I70.668, I70.691, I70.692, I70.693, I70.698, I70.701, I70.702, I70.703, I70.708, I70.711, I70.712, I70.713, I70.718, I70.721, I70.722, I70.723, I70.728, I70.731, I70.732, I70.733, I70.734, I70.735, I70.738, I70.741, I70.742. I70.743, I70.744, I70.745, I70.748, I70.761, I70.762, I70.763, I70.768, I70.791, I70.792, I70.793, and I70.798.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R4 12/01/2015 Added A48.0, I70.8, I74.09, I74.8, I96, I97.410, I97.418, I97.42, I97.610, I97.618, I97.62, and Z98.62 to Group 1 codes effective 10/01/2015. CAC information was removed.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R3 11/01/2015 Added I73.9 to Group 1 codes to use for intermittent claudication effective 10/01/2015.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R2 10/01/2015 Added Z01.810 to covered diagnostic codes. Clarification that all ICD-10 diagnostic codes listed under Group 1 Codes are supportive of medical necessity for all CPT codes listed in the policy under CPT/HCPCS Group 1. CPT codes removed from the body of the LCD.
  • Other
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R1 Failed to leave a Contractor Note
  • Other (Failed to leave a Contractor Note)
N/A

Associated Documents

Attachments
N/A
Public Versions
Updated On Effective Dates Status
10/17/2023 10/26/2023 - N/A Currently in Effect You are here
09/20/2021 10/01/2021 - 10/25/2023 Superseded View
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer